Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Pipeline Monitor
Expanded US use for Xarelto
While AZ's Lynparza gets fourth orphan nod.
Perspective
The pitfalls of political hype
Surprise! Your new drug is now a miracle cure.
Approvals Action
More generics added
Alphapharm and Boucher & Muir drugs approved.